NEXT-GEN INTERLEUKIN-2 THERAPIES: MARKET GROWTH AND INVESTMENT TRENDS

Next-Gen Interleukin-2 Therapies: Market Growth and Investment Trends Overview of the Interleukin 2 (IL-2) Market The global Interleukin 2 (IL-2) market is experiencing significant growth, driven by advancements in research and development, rising cancer and autoimmune disease rates, and the progression of immunotherapies. IL-2, a vital cytok

NSCLC Treatment Market: Immunotherapy and Targeted Therapies Leading the Way Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all lung cancer cases. As the incidence of NSCLC rises, the demand for advanced treatment options has surged, leading to significant growth in the NSCLC Drugs Market.